Management of Suspected Choledocholithiasis

Risk Stratification

The American Society for Gastrointestinal Endoscopy (ASGE) recommends a risk-stratified approach for managing suspected choledocholithiasis, with high-risk patients proceeding directly to ERCP, moderate-risk patients requiring additional confirmatory imaging, and low-risk patients managed expectantly 1, 2, 3
High-risk patients have a >50% probability of CBD stones, with very strong predictors including evidence of CBD stone on abdominal ultrasound 1, 3 and total serum bilirubin >4 mg/dL 1, 4
Strong predictors for high-risk patients also include common bile duct diameter >6 mm (with gallbladder in situ) 1, 4 and bilirubin level 1.8-4 mg/dL 1, 4

Initial evaluation for all patients should include liver biochemical tests (ALT, AST, bilirubin, ALP, GGT) 3, 5 and abdominal ultrasound 3, 5
High-risk patients should proceed directly to preoperative ERCP, intraoperative cholangiography, or laparoscopic ultrasound, depending on local expertise and availability 1, 6
Moderate-risk patients require additional confirmatory imaging, with options including preoperative MRCP (sensitivity 93%, specificity 96%) 1, 7, preoperative Endoscopic US (sensitivity 95%, specificity 97%) 1, 7, intraoperative cholangiography (sensitivity 87%, specificity 99%) 1, 7, and laparoscopic ultrasound (sensitivity 87%, specificity 100%) 1, 7

CBD stones can be removed preoperatively, intraoperatively, or postoperatively with similar success rates 1, 6
Choice of timing depends on local expertise and availability of techniques 1, 6

Potential complications of ERCP include pancreatitis, cholangitis, duodenal perforations, hemorrhage, and contrast media allergy (1-2% of patients) 1, 7
Risk of complications increases to 10% with sphincterotomy 1, 7
Elderly patients should have reduced unnecessary procedures, with same risk stratification applying but greater emphasis on avoiding complications 1, 3

The American Society for Gastrointestinal Endoscopy recognizes EUS as equivalent to MRCP for detecting common bile duct abnormalities, with both achieving sensitivities of 93-95% and specificities of 96-97% 8, 9
EUS demonstrates diagnostic accuracy comparable to ERCP, with both modalities achieving sensitivities of 95-97% for detecting common bile duct stones 8
The sensitivity of EUS ranges from 89-97%, while ERCP achieves 92-97% sensitivity, with no statistically significant difference between the two modalities 8

Transabdominal ultrasound has poor sensitivity for choledocholithiasis, ranging from 50-63%, and is appropriately used as first-line imaging to assess for biliary dilatation and gallstones, but additional testing is required when choledocholithiasis is suspected 9, 10
MRCP demonstrates high sensitivity of 77-93% for detecting choledocholithiasis, and is more sensitive than CT or transabdominal US for detection of ductal calculi 8, 11, 12
Multidetector CT is useful for detecting both bile duct strictures and stones, with sensitivity for biliary obstruction improved to >90% and sensitivity of 74-96% and specificity of 90-94% for determining the site and cause of biliary obstruction 12

The American College of Radiology reports MRCP sensitivity ranging from 77-88% with specificity between 50-72% compared to ERCP as the reference standard 12
When moderate-risk patients require confirmatory imaging for suspected choledocholithiasis, the choice between MRCP and EUS should be based on local expertise and availability, as both achieve comparable diagnostic accuracy 8
ERCP should be reserved for therapeutic intervention when stones are confirmed or for high-risk patients where immediate treatment is anticipated, due to the 1-2% complication rate 9, 11